Basic brain mechanisms underlying drug addiction, craving, and relapse
Basic brain mechanisms underlying drug addiction, craving, and relapse
批准号:
7593286
负责人:
ELIOT L GARDNER
金额:
$37.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AcuteAddictive BehaviorAdolescentAdultAmphetaminesAmygdaloid structureAnimal ModelAnimalsAttenuatedBehaviorBilateralBiochemicalBiological AssayBiological ModelsBrainCannabinoidsCerebellumConditionCorpus striatum structureCuesDevelopmentDopamineDrug AddictionElectrical Stimulation of the BrainExposure toFluorineGoalsHigh Pressure Liquid ChromatographyImageImmunoblottingInjection of therapeutic agentIntravenousLaboratory AnimalsLaboratory PersonnelLaboratory RatLiteratureMedicineMetabolismMethamphetamineMicrodialysisMotor CortexOpioidPain managementPharmaceutical PreparationsPolymerase Chain ReactionPositron-Emission TomographyProteinsPsychological reinforcementPsychostimulant dependenceRNARacloprideRangeRelapseReportingResearchResearch Project GrantsResourcesReverse TranscriptionRewardsRiskSamplingScanningSelf AdministrationStressTechniquesTemporal LobeThalamic structureVigabatrinWestern BlottingWorkaddictioncravingdaydopamine D3 receptorenantiomerfluorodeoxyglucosegamma-Aminobutyric Acidin vivoinsightinterestmature animalmedian forebrain bundleneuroimagingnovelpre-clinicalpreferencesensory cortexuptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Due to diversion of laboratory personnel and resources to the dopamine D3 receptor, GABA, and cannabinoid research projects during the reporting period (01 Oct 06 to 30 Sept 07), only limited progress was made on this research project. During the reporting period, we used small animal positron emission tomography (PET) neuroimaging in combination with 11C-raclopride and fluorine-18 fluorodeoxyglucose (FDG) to examine methamphetamine-induced alterations in brain dopamine and metabolism. Adolescent laboratory rats (30 days old) received baseline microPET scans. The animals then received an injection of methamphetamine, followed by another set of microPET scans. Methamphetamine significantly increased striatal dopamine by approximately 22% and increased FDG uptake cortically, subcortically, and in the cerebellum. There were no effects of methamphetamine on occipital FDG uptake. Acute pretreatment with S-(+)-gamma-vinyl-GABA completely abolished these increases. This constitutes the first finding that racemic gamma-vinyl-GABA's effects on brain mechanisms may be due to actions of the S-(+)-gamma-vinyl-GABA enantiomer. As adults (>90 days old), the animals received another methamphetamine injection followed by microPET scanning. Adolescent exposure to S-(+)-gamma-vinyl-GABA attenuated methamphetamine-induced changes in FDG uptake in these adult animals. We also used a unqiue serial imaging strategy to obtain FDG microPET images both prior to and during the expression of methamphetamine-induced conditioned place preferences. We studied animals during both "forced exposure" and "free choice exposure" to the environmental cues previously associated with methamphetamine administration. We found that both types of exposure to amphetamine-paired environmental cues produced significant bilateral activations of motor cortex, temporal cortex, cerebellum, and thalamus. However, "free choice exposure" preferentially activated the medial forebrain bundle and striatum, while "forced exposure" preferentially activated the amygdala and sensory cortex. We also contributed 3 major review articles to the addiction medicine literature during this this reporting period - one on the "risk" of addiction during pain management with opioid medications, one on hypotheis-driven medication discovery for the treatment of psychostimulant addiction, and one on animal models of addiction.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ALCOHOL REWARD AND BRAIN DOPAMINE--PHARMACO-MODULATIONS
-
批准号:3443564
-
项目类别:
-
资助金额:$11.61万
-
财政年份:1992
-
负责人:ELIOT L GARDNER
-
依托单位:
ALCOHOL REWARD AND BRAIN DOPAMINE--PHARMACO-MODULATIONS
-
批准号:2045789
-
项目类别:
-
资助金额:$11.56万
-
财政年份:1992
-
负责人:ELIOT L GARDNER
-
依托单位:
CLOZAPIN--CHOLINERGIC BASIS OF MESOLIMBIC SPECIFICITY
-
批准号:3428725
-
项目类别:
-
资助金额:$4.66万
-
财政年份:1988
-
负责人:ELIOT L GARDNER
-
依托单位:
MARIJUANA & DOPAMINE/ENKEPHALIN BRAIN REWARD SYSTEMS
-
批准号:2116776
-
项目类别:
-
资助金额:$18.82万
-
财政年份:1984
-
负责人:ELIOT L GARDNER
-
依托单位:
MARIJUANA & DOPAMINE/ENKEPHALIN BRAIN REWARD SYSTEMS
-
批准号:3208158
-
项目类别:
-
资助金额:$20.59万
-
财政年份:1984
-
负责人:ELIOT L GARDNER
-
依托单位:
MARIJUANA AND DOPAMINE/ENKEPHALIN BRAIN REWARD SYSTEMS
-
批准号:3208159
-
项目类别:
-
资助金额:$15.52万
-
财政年份:1984
-
负责人:ELIOT L GARDNER
-
依托单位:
MARIJUANA AND DOPAMINE/ENKEPHALIN BRAIN REWARD SYSTEMS
-
批准号:3208160
-
项目类别:
-
资助金额:$14.55万
-
财政年份:1984
-
负责人:ELIOT L GARDNER
-
依托单位:
Dopamine D3 receptor antagonists for treating drug addiction: Preclinical models
-
批准号:7733810
-
项目类别:
-
资助金额:$38.96万
-
财政年份:--
-
负责人:ELIOT L GARDNER
-
依托单位:
Glutamatergic compounds for treating drug addiction: Preclinical models
-
批准号:7733812
-
项目类别:
-
资助金额:$31.17万
-
财政年份:--
-
负责人:ELIOT L GARDNER
-
依托单位:
Slow-onset long-acting dopamine transport inhibitors for treating drug addiction
-
批准号:7593285
-
项目类别:
-
资助金额:$37.0万
-
财政年份:--
-
负责人:ELIOT L GARDNER
-
依托单位:
Glutamatergic compounds for treating drug addiction: Pre
-
批准号:7321124
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ELIOT L GARDNER
-
依托单位:
GABAergic compounds-treating drug addiction: Preclinical
-
批准号:7149329
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ELIOT L GARDNER
-
依托单位:
GABAergic compounds for treating drug addiction: Preclinical models
-
批准号:7733811
-
项目类别:
-
资助金额:$31.17万
-
财政年份:--
-
负责人:ELIOT L GARDNER
-
依托单位:
Dopamine D3 receptor antagonists-treating drug addiction
-
批准号:7149328
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ELIOT L GARDNER
-
依托单位:
Basic brain mechanisms underlying drug addiction, cravin
-
批准号:7321126
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ELIOT L GARDNER
-
依托单位:
Glutamatergic compounds for treating drug addiction
-
批准号:7149330
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ELIOT L GARDNER
-
依托单位:
Slow-onset long-acting dopamine transport inhibitors
-
批准号:7149331
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ELIOT L GARDNER
-
依托单位:
Slow-onset long-acting dopamine transport inhibitors for
-
批准号:7321125
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ELIOT L GARDNER
-
依托单位:
Dopamine D3 receptor antagonists for treating drug addiction: Preclinical models
-
批准号:7593282
-
项目类别:
-
资助金额:$46.26万
-
财政年份:--
-
负责人:ELIOT L GARDNER
-
依托单位:
Slow-onset long-acting dopamine transport inhibitors for treating drug addiction
-
批准号:7733813
-
项目类别:
-
资助金额:$31.17万
-
财政年份:--
-
负责人:ELIOT L GARDNER
-
依托单位:
海外基金